HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jianfeng Zhou Selected Research
Jianfeng Zhou Research Topics
Disease
130
Neoplasms (Cancer)
11/2022 - 12/2004
31
Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 01/2004
23
Neoplasm Metastasis (Metastasis)
10/2021 - 01/2005
22
Leukemia
01/2022 - 01/2005
21
Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2020 - 09/2005
16
Lymphoma (Lymphomas)
01/2022 - 01/2005
14
Multiple Myeloma
01/2022 - 12/2010
13
Hematologic Neoplasms (Hematological Malignancy)
06/2022 - 01/2004
12
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 06/2012
12
Infections
01/2022 - 02/2014
11
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2011
10
Carcinogenesis
01/2022 - 07/2005
10
Carcinoma (Carcinomatosis)
08/2019 - 01/2004
9
COVID-19
01/2022 - 01/2020
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2022 - 08/2012
8
Hemorrhage
02/2022 - 06/2016
8
Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2018
8
Breast Neoplasms (Breast Cancer)
01/2014 - 01/2006
6
Disease Progression
01/2022 - 04/2008
6
Hypoxia (Hypoxemia)
01/2021 - 02/2008
5
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2022 - 04/2016
5
Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 01/2005
5
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 01/2018
5
Prostatic Neoplasms (Prostate Cancer)
02/2015 - 06/2007
4
Hodgkin Disease (Hodgkin's Disease)
01/2022 - 01/2019
4
Residual Neoplasm
05/2021 - 09/2014
4
Aplastic Anemia (Anemia, Hypoplastic)
02/2014 - 01/2004
4
Lymphatic Metastasis
11/2010 - 03/2008
3
Lymphopenia (Lymphocytopenia)
11/2022 - 01/2019
3
Glioma (Gliomas)
01/2022 - 01/2016
3
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 01/2020
3
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 11/2015
3
Cytokine Release Syndrome
01/2022 - 12/2020
3
Neutropenia
01/2022 - 12/2015
3
Virus Diseases (Viral Diseases)
10/2021 - 12/2009
3
Hypertension (High Blood Pressure)
10/2021 - 01/2020
3
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2021 - 01/2015
3
Hematologic Diseases (Blood Diseases)
09/2020 - 02/2011
3
Femoral Neck Fractures
04/2020 - 01/2018
3
Splenomegaly
01/2020 - 10/2015
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 01/2010
3
Stomach Neoplasms (Stomach Cancer)
10/2017 - 01/2012
3
Retinoblastoma (Glioblastoma, Retinal)
01/2015 - 08/2007
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2014 - 08/2012
Drug/Important Bio-Agent (IBA)
39
Chimeric Antigen Receptors
IBA
06/2022 - 01/2018
36
Proteins (Proteins, Gene)
FDA Link
12/2022 - 07/2004
15
Biological Products
IBA
01/2022 - 01/2007
13
Cisplatin (Platino)
FDA Link
Generic
04/2014 - 07/2004
12
Cytokines
IBA
01/2022 - 01/2009
12
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2010
9
Messenger RNA (mRNA)
IBA
12/2022 - 01/2004
9
Antigens
IBA
01/2022 - 03/2010
9
Histone Deacetylase Inhibitors
IBA
06/2017 - 09/2005
9
Small Interfering RNA (siRNA)
IBA
01/2017 - 02/2008
8
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
01/2022 - 10/2018
7
Peptides (Polypeptides)
IBA
02/2014 - 01/2006
6
DNA (Deoxyribonucleic Acid)
IBA
08/2022 - 10/2006
6
zanubrutinib
IBA
01/2022 - 01/2020
6
Vaccines
IBA
02/2020 - 09/2009
6
trichostatin A (A 300)
IBA
06/2017 - 09/2005
6
theasinensin A
IBA
06/2017 - 09/2005
6
Phosphotransferases (Kinase)
IBA
04/2016 - 01/2005
5
Pharmaceutical Preparations
IBA
11/2022 - 04/2005
5
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2022 - 01/2020
5
Enzymes
IBA
01/2020 - 02/2006
5
Survivin
IBA
08/2019 - 07/2005
5
Complementary DNA (cDNA)
IBA
11/2011 - 12/2005
4
Monoclonal Antibodies
IBA
02/2022 - 06/2012
4
Acids
IBA
01/2022 - 09/2008
4
Transcription Factors (Transcription Factor)
IBA
10/2021 - 10/2003
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2021 - 04/2006
4
Ferritins (Ferritin)
IBA
07/2020 - 10/2015
4
Elements
IBA
04/2020 - 01/2018
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020 - 02/2014
4
Caspase 3 (Caspase-3)
IBA
01/2011 - 07/2004
4
Aromatase (CYP19)
IBA
02/2006 - 05/2002
3
RNA (Ribonucleic Acid)
IBA
01/2022 - 06/2010
3
B-Cell Maturation Antigen
IBA
12/2021 - 10/2018
3
N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamide
IBA
10/2021 - 01/2017
3
Circulating Tumor DNA
IBA
05/2021 - 01/2019
3
Antineoplastic Agents (Antineoplastics)
IBA
01/2021 - 09/2008
3
HMPL-013
IBA
01/2021 - 01/2018
3
Interleukins
IBA
01/2020 - 06/2011
3
Interleukin-6 (Interleukin 6)
IBA
01/2020 - 12/2013
3
Ubiquitin
IBA
11/2019 - 01/2013
3
Fluorouracil (Carac)
FDA Link
Generic
08/2019 - 01/2010
3
Platinum
IBA
10/2018 - 11/2013
3
Thymidine Kinase
IBA
01/2018 - 10/2007
3
Bortezomib (Velcade)
FDA Link
06/2017 - 05/2011
3
TOR Serine-Threonine Kinases
IBA
12/2014 - 10/2011
3
Fibronectins (Fibronectin)
IBA
08/2013 - 07/2007
3
Oligonucleotides
IBA
01/2012 - 12/2004
Therapy/Procedure
77
Therapeutics
11/2022 - 01/2006
22
Drug Therapy (Chemotherapy)
01/2022 - 07/2004
21
Immunotherapy
01/2022 - 06/2007
10
Stem Cell Transplantation
01/2022 - 01/2015
7
Transplantation
01/2022 - 05/2013
7
Hematopoietic Stem Cell Transplantation
01/2022 - 01/2004
5
Radiotherapy
01/2022 - 11/2008
3
Heterologous Transplantation (Xenotransplantation)
01/2013 - 08/2012